Are recommended standards for diabetes care met in Central and South America? A systematic review

Diabetes Research and Clinical Practice

Volumn 100, Issue 3, 2013, Pages 306-329

  Mudaliar, Uma ^a   Kim, Woon Cho ^a,b   Kirk, Katy ^b   Rouse, Chaturia ^c   Narayan, K M Venkat ^a,b   Ali, Mohammed ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Central America; Diabetes; Latin America; Quality of care; Review; South America

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

BLOOD PRESSURE; CENTRAL AMERICA; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; RISK MANAGEMENT; SOCIOECONOMICS; SOUTH AMERICA; SYSTEMATIC REVIEW;

BRAZIL; CENTRAL AMERICA; DIABETES MELLITUS; HUMANS; JAMAICA; MEXICO; QUALITY OF HEALTH CARE; SOUTH AMERICA;

EID: 84878490345     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.01.010     Document Type: Review

References (70)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329(14):977-986.
2. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352(9131):854-865.
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853.
4. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317(7160):703-713.
5. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011, C.f.D.C.a. Prevention, Editor 2011: Atlanta.
6. Aguilar-Salinas C.A., Velazquez Monroy O., Gomez-Perez F.J., Gonzalez Chavez A., Esqueda A.L., Molina Cuevas V., et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survey. Diabetes Care 2003, 26:2021-2026.
7. Assuncao M.C.F., Santos I.S., Valle N.C.J. Blood glucose control in diabetes patients seen in primary health care centers. Rev Saude Publica 2005, 39:183-190.
8. Bank, W. Country and Lending Groups 2011, available at: http://data.worldbank.org/about/country-classifications/country-and-lending-groups%23LAC.
9. Barcelo A. The Central America Diabetes Initiative (CAMDI) P.o.N.-C. Diseases, Editor 2002 2002, Pan American Health Organization/WHO, Washington, DC.
10. Barcelo A., Aedo C., Rajpathak S., Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 2003, 81:19-27.
11. Barcelo A., Cafiero E., de Boer M., Mesa A.E., Lopez M.G., Jimenez R.A., et al. Using collaborative learning to improve diabetes care and outcomes: the VIDA project. Prim Care Diabetes 2010, 4:145-153.
12. Bautista-Martinez S., Aguilar-Salinas C.A., Lerman I., Velasco M.L., Castellanos R., Zenteno E., et al. Diabetes knowledge and its determinants in a Mexican population. Diabetes Educ 1999, 25:374-381.
13. Beckles G.L., Engelgau M.M., Narayan K.M., Herman W.H., Aubert R.E., Williamson D.F. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 1998, 21:1432-1438.
14. Brechner R.J., Cowie C.C., Howie L.J., Herman W.H., Will J.C., Harris M.I. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993, 270:1714-1718.
15. Brenes-Camacho G., Rosero-Bixby L. Metabolic control in a nationally representative diabetic elderly sample in Costa Rica: patients at community health centers vs. patients at other health care settings. BMC Int Health Hum Rights 2008, 8.
16. Chan J.C.N., Gagliardino J.J., Baik S.H., Chantelot J.M., Ferreira S.R.G., Hancu N., et al. Multifaceted determinants for achieving glycemic control the international diabetes management practice study (IDMPS). Diabetes Care 2009, 32:227-233.
17. Chaves-Fonseca R.M., Matos O.S., Lordelo R.A., Abreu M., Farias M.G., Coutinho J.F., et al. Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorizacao da Assistencia ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia). Diabet Med 2009, 26:286-292.
18. Compean Ortiz L.G., Gallegos Cabriales E.C., Gonzalez Gonzalez J.G., Gomez Meza M.V. Self-care behaviors and health indicators in adults with type 2 diabetes. Rev Lat Am Enfermagem 2010, 18:675-680.
19. Correr C.J., Melchiors A.C., Fernandez-Llimos F., Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm 2011, 33:273-280.
20. Cueto-Manzano A.M., Cortes-Sanabria L., Martinez-Ramirez H.R., Rojas-Campos E., Barragan G., Alfaro G., et al. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus. Kidney Int Suppl 2005, S40-S45.
21. Diaz-Apodaca B.A., de Cosio F.G., Canela-Soler J., Ruiz-Holguin R., Cerqueira M.T. Quality of diabetes care: a cross-sectional study of adults of Hispanic origin across and along the United States-Mexico border. Rev Panam Salud Publica 2010, 28:207-213.
22. Dijkstra R., Braspenning J., Grol R. Empowering patients: how to implement a diabetes passport in hospital care. Patient Educ Couns 2002, 47:173-177.
23. Duff E.M., O'Connor A., McFarlane-Anderson N., Wint Y.B., Bailey E.Y., Wright-Pascoe R.A. Self-care, compliance and glycaemic control in Jamaican adults with diabetes mellitus. West Indian Med J 2006, 55:232-236.
24. Egede L.E., Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract 2010, 87:302-312.
25. Egede L.E., Ellis C. The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes. Diabetes Technol Ther 2010, 12:257-262.
26. Egede L.E., Ellis C., Grubaugh A.L. The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry 2009, 31:422-427.
27. Esteves J.F., Kramer C.K., Azevedo M.J., Stolz A.P., Roggia M.F., Larangeira A., et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Rev Assoc Med Bras 2009, 55:268-273.
28. Feder G., Eccles M., Grol R., Griffiths C., Grimshaw J. Using clinical guidelines. BMJ 1999, 318:728-730.
29. Gaede P., Lund-Andersen H., Parving H.-H., Pedersen O. Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. N Engl J Med 2008, 358:580-591.
30. Gagliardino J.J., Lapertosa S., Villagra M., Caporale J.E., Oliver P., Gonzalez C., et al. PRODIACOR: a patient-centered treatment program for type 2 diabetes and associated cardiovascular risk factors in the city of Corrientes, Argentina: study design and baseline data. Contemp Clin Trials 2007, 28:548-556.
31. Gagliardino J.J., Olivera E., Etchegoyen G.S., Guidi M.L., Caporale J.E., Martella A., et al. PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 2006, 72:284-291.
32. Gakidou E., Mallinger L., Abbott-Klafter J., Guerrero R., Villalpando S., Ridaura R.L., et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ 2011, 89:172-183.
33. Garay-Sevilla Ma E., Nava L.E., Malacara J.M., Huerta R., Diaz De Leon J., Mena A., et al. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diabetes Complications 1995, 9:81-86.
34. Gonzalez Villalpando C., Stern M.P., Arredondo Perez B., Martinez Diaz S. The level of metabolic control in low income Mexico City Diabetics. The Mexico City Diabetes Study. Arch Med Res 1994, 25:387-392.
35. Gonzalez Villalpando C., Stern M.P., Arredondo Perez B., Martinez Diaz S., Islas Andrade S., Revilla C., et al. Nephropathy in low income diabetics: the Mexico City Diabetes Study. Arch Med Res 1996, 27:367-372.
36. Gonzalez Villalpando M.E., Gonzalez Villalpando C., Arredondo Perez B., Martinez Diaz S.V., Mitchell B., Rivera Martinez D., et al. Moderate-to-severe diabetic retinopathy is more prevalent in Mexico City than in San Antonio, Texas. Diabetes Care 1997, 20:773-777.
37. Grol R.G., Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. The Lancet 2003 10 11, 362:1225-1230.
38. Guzman J.R., Lyra R., Aguilar-Salinas C.A., Cavalcanti S., Escano F., Tambasia M., et al. Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Latin American Diabetes Association. Rev Panam Salud Publica 2010, 28:463-471.
39. Hansson L., Zanchetti A., Carruthers S.G., Dahlof B., Elmfeldt D., Julius S., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351:1755-1762.
40. IDF Global Guideline for Type 2 Diabetes. 2005.
41. International Diabetes Federation, IDF Diabetes Atlas, 5th edn., in, International Diabetes Federation, Brussels, Belgium, 2011.
42. Jha A.K., Li Z., Orav E.J., Epstein A.M. Care in U.S. hospitals--the Hospital Quality Alliance program. N Engl J Med 2005, 353:265-274.
43. Jimenez-Corona A., Rojas R., Gomez-Perez F.J., Aguilar-Salinas C.A. Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010, 52(Suppl 1):S27-S35.
44. Joshi M.S., Bernard D.B. Clinical performance improvement series. Classic CQI integrated with comprehensive disease management as a model for performance improvement. Jt Comm J Qual Improv 1999, 25:383-395.
45. Kenny S.J., Smith P.J., Goldschmid M.G., Newman J.M., Herman W.H. Survey of physician practice behaviors related to diabetes mellitus in the U.S. Physician adherence to consensus recommendations. Diabetes Care 1993, 16:1507-1510.
46. Kim C.K.H., Bae S., Park J., Lee K. Discordance between fasting glucose-based and hemoglobin A1c-based diagnosis of diabetes mellitus in Koreans. Diabetes Res Clini Pract 2011, 91:e8-e10.
47. Lerman I., Lozano L., Villa A.R., Hernandez-Jimenez S., Weinger K., Caballero A.E., et al. Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City. Biomed Pharmacother 2004, 58:566-570.
48. Less L.A., Ragoobirsingh D., Morrison E.Y., Boyne M., Johnson P.A. A preliminary report on an assessment of a community-based intervention for diabetes control in adults with type 2 diabetes. Fam Pract 2010, 27(Suppl 1):i46-i52.
49. Lopez Stewart G., Tambascia M., Rosas Guzman J., Etchegoyen F., Ortega Carrion J., Artemenko S. Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America. Rev Panam Salud Publica 2007, 22:12-20.
50. Machado-Alba J.E., Moncada-Escobar J.C., Gaviria H. Quality and effectiveness of diabetes care for a group of patients in Colombia. Rev Panam Salud Publica 2009, 26:529-535.
51. Martinez J., Hernandez-Bogantes E., Wu L. Diabetic retinopathy screening using single-field digital fundus photography at a district level in Costa Rica: a pilot study. Int Ophthalmol 2011, 31:83-88.
52. Mendes A.B., Fittipaldi J.A., Neves R.C., Chacra A.R., Moreira E.D. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol 2010, 47:137-145.
53. Moreira E.D., Neves R.C., Nunes Z.O., de Almeida M.C., Mendes A.B., Fittipaldi J.A., et al. Glycemic control and its correlates in patients with diabetes in Venezuela: results from a nationwide survey. Diabetes Res Clin Pract 2010, 87:407-414.
54. Mourao C.A. 2nd, J.R. de Sa, O.M. Guedes, S.A. Dib, Glycemic control in adult type 1 diabetes patients from a brazilian country city: comparison between a multidisciplinary and a routine endocrinological approach. Arq Bras Endocrinol Metabol 2006, 50:944-950.
55. Paisey R.B., Arredondo G., Villalobos A., Lozano O., Guevara L., Kelly S. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II. Diabetes Care 1984, 7:428-433.
56. Pena-Valdovinos A., Jimenez-Cruz A., Leyva-Pacheco R., Bacardi-Gascon M. Metabolic control in diabetic patients at the primary care level in Mexico. Diabetes Res Clin Pract 1997, 37:179-184.
57. Raheja B.S., Kapur A., Bhoraskar A., Sathe S.R., Jorgensen L.N., Moorthi S.R., et al. DiabCare Asia--India Study: diabetes care in India--current status. J Assoc Physicians India 2001, 49:717-722.
58. Reynoso-Noveron N., Mehta R., Almeda-Valdes P., Rojas-Martinez R., Villalpando S., Hernandez-Avila M., et al. Estimated incidence of cardiovascular complications related to type 2 diabetes in Mexico using the UKPDS outcome model and a population-based survey. Cardiovasc Diabetol 2011, 10:1.
59. Ringborg A., Cropet C., Jonsson B., Gagliardino J.J., Ramachandran A., Lindgren P. Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). Int J Clin Pract 2009, 63:997-1007.
60. Rodriguez-Saldana J., Rosales-Campos A.C., Rangel Leon C.B., Vazquez-Rodriguez L.I., Martinez-Castro F., Piette J.D. Quality of previous diabetes care among patients receiving services at ophthalmology hospitals in Mexico. Rev Panam Salud Publica 2010, 28:440-445.
61. Saaddine J.B., Engelgau M.M., Beckles G.L., Gregg E.W., Thompson T.J., Narayan K.M.V. A diabetes report card for the united states: quality of care in the 1990s. Ann Intern Med 2002, 136:565-574.
62. Sadur C.N., Moline N., Costa M., Michalik D., Mendlowitz D., Roller S., et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care 1999, 22:2011-2017.
63. Sosa-Rubi S.G., Galarraga O., Lopez-Ridaura R. Diabetes treatment and control: the effect of public health insurance for the poor in Mexico. Bull World Health Organ 2009, 87:512-519.
64. Swaby P., Wilson E., Swaby S., Sue-Ho R., Pierre R. Chronic disease control and compliance--the HOPE worldwide Jamaica experience. West Indian Med J 2001, 50(Suppl 1):51-53.
65. Swaby P., Wilson E., Swaby S., Sue-Ho R., Pierre R. Chronic diseases management in the Jamaican setting: HOPE worldwide Jamaica's experience. P N G Med J 2001, 44:171-175.
66. Tulloch-Reid M.K., Boyne M.S., Smikle M.F., Choo-Kang E.G., Parkes R.H., Wright-Pascoe R.A., et al. Cardiovascular risk profile in Caribbean youth with diabetes mellitus. West Indian Med J 2009, 58:219-226.
67. Tulloch-Reid M.K., Boyne M.S., Smikle M.F., Choo-Kang E.G., Parkes R.H., Wright-Pascoe R.A., et al. Clinical and laboratory features of youth onset type 2 diabetes in Jamaica. West Indian Med J 2010, 59:131-138.
68. Vijayaraghavan M., He G., Stoddard P., Schillinger D. Blood pressure control, hypertension, awareness, and treatment in adults with diabetes in the United States-Mexico border region. Rev Panam Salud Publica 2010, 28:164-173.
69. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia [cited 2012 November 3], available at: 2006. http://www.idf.org/diabetesatlas/5e/the-global-burden.
70. Wilks R.J., Sargeant L.A., Gulliford M.C., Reid M.E., Forrester T.E. Management of diabetes mellitus in three settings in Jamaica. Rev Panam Salud Publica 2001, 9:65-72.